"Merck and Schering-Plough also recently received subpoenas dated April 4, 2008 from the Office of the New Jersey Attorney General seeking documents related to the ENHANCE trial and the sales and marketing of VYTORIN." See Merck quarterly report.
NJ's own AG Anne Milgram in action:
No comments:
Post a Comment